Laval, Canada

Julien Martel

This inventor holds 2 USPTO granted patents and 6 published patent applications. Top assignee: Liminal Biosciences Limited. Active years: 2025-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Julien Martel. Retrieved from https://idiyas.com/inventor/julien-martel-i2i9e86p

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

% Patents Active = 50.0

Average Co-Inventor Count = 9.0

ph-index = 1


Company Filing History:


Years Active: 2025-2026

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations of Julien Martel

Introduction

Julien Martel is an accomplished inventor based in Laval, Canada. He has made significant contributions to the field of biomedical research, particularly in the development of compounds that target specific biological pathways.

Latest Patents

One of his notable patents is related to GPR84 antagonists and their uses. The present invention provides compounds, compositions thereof, and methods of using the same for the inhibition of GPR84, and the treatment of GPR84-mediated disorders. This patent highlights his innovative approach to addressing complex medical conditions.

Career Highlights

Julien Martel is associated with Liminal Biosciences Limited, where he applies his expertise in drug development and research. His work focuses on creating therapeutic solutions that can improve patient outcomes.

Collaborations

He collaborates with talented professionals in his field, including Shaun Abbott and Mylène De Léséleuc. These partnerships enhance the research and development efforts at Liminal Biosciences Limited.

Conclusion

Julien Martel's contributions to the field of biomedical research through his innovative patents and collaborations demonstrate his commitment to advancing medical science. His work continues to pave the way for new treatments and therapies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…